July 13, 2021


Boehringer Ingelheim's smartphone app brings pig vaccination to next level




Boehringer Ingelheim has announced that its FreVAX™ intramuscular needle-free device can now be managed via the new version of the FreVAX™ smartphone app.


The '2.0' version of the FreVAX™ app unlocks new features and possibilities:


- Easy management of vaccination events including date, location, pig group and age, dose, vaccines used and caregiver associated with actual vaccination sessions compliance;


- Advanced device usage interface with self-diagnostics and multiple languages settings;


- Improved support with access to online helpdesk, FAQs and return process if needed;


- Export of consistent vaccination reports with high data quality.


The FreVAX™ app 2.0 can now be downloaded for free from App Store and Google Play.


The FreVAX™ intramuscular needle-free device has been available since December 2020 to swine producers worldwide. It is commercially available in 31 countries and can transfer vaccination data to the app, allowing remote, real-time data analysis including detailed vaccination session reports.


Around 500 FreVAX™ devices have been shipped to various countries this year.


"There is no doubt an increasing interest in needle-free devices due to the added benefits regarding pig safety and welfare leading to improved meat quality," Dr. Markus Hammer, global head of swine at Boehringer Ingelheim Animal Health, said. "At the same time, veterinarians and progressive swine producers are looking for convenient and reliable tools in the farm with a big focus on the vaccination process."


"We now have an offering that incorporates an accurate, safe, needle-free  intramuscular administration method with the new FreVAX™ app 2.0 to provide  improved vaccination compliance and data management," said Marius Leyhausen, senior global brand manager of integrated health management.


- Boehringer Ingelheim